Skip to main content

Table 1 Correlation between the clinicopathological traits and piRNA-14633 expression in cervical carcinoma patients

From: piRNA-14633 promotes cervical cancer cell malignancy in a METTL14-dependent m6A RNA methylation manner

 

Total

n%

P

Low expression

High expression

of piRNA-14633

of piRNA-14633

Age

    

 ≥ 55 (years)

55

25 (45.5%)

30 (54.5%)

0.755

 < 55 (years)

39

19 (48.7%)

20 (51.3%)

 

T stage

    

 T1-T2

49

30 (61.2%)

19 (38.8%)

0.003*

 T3-T4

45

14 (31.1%)

31 (68.9%)

 

N stage

    

 N1

42

27 (64.3%)

15 (35.7%)

0.002*

 N2

52

17 (32.7%)

35 (67.3%)

 

M stage

    

 M0

34

22 (64.7%)

12 (35.3%)

0.009*

 M1

60

22 (36.7%)

38 (63.3%)

 

Tumor size (cm)

    

 < 4

41

25 (61.0%)

16 (39.0%)

0.015*

 ≥ 4

53

19 (35.8%)

34 (64.2%)

 
  1. T stage: Primary tumor stage; N stage: Regional lymph nodes stages; M stage: Distant metastasis stage